Derek Ng Tang

1.5k total citations
18 papers, 1.2k citations indexed

About

Derek Ng Tang is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Derek Ng Tang has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Derek Ng Tang's work include Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (6 papers). Derek Ng Tang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (6 papers). Derek Ng Tang collaborates with scholars based in United States, Spain and Canada. Derek Ng Tang's co-authors include Padmanee Sharma, Jingjing Sun, Christopher J. Logothetis, Chrysoula I. Liakou, Ashish M. Kamat, Patricia Troncoso, Hong Chen, Andrew P. Rice, Dorothy E. Lewis and Jingjing Sun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Derek Ng Tang

18 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Derek Ng Tang United States 10 811 757 281 123 97 18 1.2k
Susanne H.C. Baumeister United States 10 637 0.8× 598 0.8× 175 0.6× 71 0.6× 87 0.9× 19 1.0k
Cecilia Rietz United States 9 694 0.9× 611 0.8× 178 0.6× 44 0.4× 80 0.8× 13 973
Julius Juaréz Australia 14 381 0.5× 474 0.6× 231 0.8× 157 1.3× 55 0.6× 19 991
Vanessa Arfi France 8 433 0.5× 592 0.8× 223 0.8× 200 1.6× 40 0.4× 8 951
Manuel Schmidt Germany 14 353 0.4× 603 0.8× 273 1.0× 73 0.6× 34 0.4× 50 1.0k
Jianping Yang New Zealand 20 403 0.5× 822 1.1× 256 0.9× 32 0.3× 110 1.1× 44 1.1k
Kellie N. Smith United States 15 409 0.5× 352 0.5× 206 0.7× 67 0.5× 174 1.8× 42 756
Maximillian Rosario United States 11 541 0.7× 945 1.2× 150 0.5× 116 0.9× 25 0.3× 19 1.1k
William Shingler United Kingdom 13 380 0.5× 435 0.6× 191 0.7× 62 0.5× 116 1.2× 26 697
Antonio Polley United States 5 883 1.1× 1.5k 2.0× 177 0.6× 131 1.1× 64 0.7× 5 1.9k

Countries citing papers authored by Derek Ng Tang

Since Specialization
Citations

This map shows the geographic impact of Derek Ng Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Ng Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Ng Tang more than expected).

Fields of papers citing papers by Derek Ng Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek Ng Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Ng Tang. The network helps show where Derek Ng Tang may publish in the future.

Co-authorship network of co-authors of Derek Ng Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Derek Ng Tang. A scholar is included among the top collaborators of Derek Ng Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek Ng Tang. Derek Ng Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Poon, Candice C., Shelley M. Herbrich, Yulong Chen, et al.. (2025). Mesenchymal Stem Cells and Fibroblasts Contribute to Microvascular Proliferation in Glioblastoma and are Correlated with Immunosuppression and Poor Outcome. Cancer Immunology Research. 13(6). 804–820. 2 indexed citations
2.
Anandhan, Swetha, Shelley M. Herbrich, Sangeeta Goswami, et al.. (2024). TSG-6+ cancer-associated fibroblasts modulate myeloid cell responses and impair anti-tumor response to immune checkpoint therapy in pancreatic cancer. Nature Communications. 15(1). 5291–5291. 8 indexed citations
3.
Shi, Lewis Z., Sangeeta Goswami, Tihui Fu, et al.. (2019). Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner. Cancer Immunology Research. 7(11). 1803–1812. 35 indexed citations
5.
Chen, Hong, Tihui Fu, Woong‐Kyung Suh, et al.. (2013). CD4 T Cells Require ICOS-Mediated PI3K Signaling to Increase T-Bet Expression in the Setting of Anti-CTLA-4 Therapy. Cancer Immunology Research. 2(2). 167–176. 44 indexed citations
6.
Tang, Derek Ng, Yu Shen, Jingjing Sun, et al.. (2013). Increased Frequency of ICOS+ CD4 T Cells as a Pharmacodynamic Biomarker for Anti-CTLA-4 Therapy. Cancer Immunology Research. 1(4). 229–234. 146 indexed citations
7.
Gao, Jianjun, Hong Chen, Derek Ng Tang, & Padmanee Sharma. (2013). A study of genes and microRNAs that may predict clinical responses to anti-CTLA-4 therapy.. Journal of Clinical Oncology. 31(6_suppl). 285–285. 1 indexed citations
8.
Aparicio, Ana M., Jingjing Sun, Derek Ng Tang, et al.. (2012). Abstract 5368: A phase II study of ipilumimab plus androgen deprivation therapy in castration-sensitive prostate carcinoma. Cancer Research. 72(8_Supplement). 5368–5368. 1 indexed citations
9.
Gao, Jianjun, Jingjing Sun, John F. Ward, et al.. (2012). Abstract 4388: Combination therapy with anti-CTLA-4 plus leuprolide acetate in the pre-surgical setting of patients with regional, high-risk prostate cancer. Cancer Research. 72(8_Supplement). 4388–4388. 1 indexed citations
10.
Sun, Jingjing, Derek Ng Tang, Tihui Fu, & Padmanee Sharma. (2011). Identification of Human Regulatory T Cells in the Setting of T-Cell Activation and Anti–CTLA-4 Immunotherapy on the Basis of Expression of Latency-Associated Peptide. Cancer Discovery. 2(2). 122–130. 23 indexed citations
11.
Gnjatic, Sacha, Nasser K. Altorki, Derek Ng Tang, et al.. (2009). NY-ESO-1 DNA Vaccine Induces T-Cell Responses That Are Suppressed by Regulatory T Cells. Clinical Cancer Research. 15(6). 2130–2139. 58 indexed citations
12.
Chen, Hong, Chrysoula I. Liakou, Ashish M. Kamat, et al.. (2009). Anti-CTLA-4 therapy results in higher CD4 + ICOS hi T cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues. Proceedings of the National Academy of Sciences. 106(8). 2729–2734. 164 indexed citations
13.
Liakou, Chrysoula I., Ashish M. Kamat, Derek Ng Tang, et al.. (2008). CTLA-4 blockade increases IFNγ-producing CD4 + ICOS hi cells to shift the ratio of effector to regulatory T cells in cancer patients. Proceedings of the National Academy of Sciences. 105(39). 14987–14992. 428 indexed citations
14.
Sharma, Padmanee, Chrysoula Liakou, Ashish M. Kamat, et al.. (2008). Immunological impact of anti-CTLA4 therapy in a neoadjuvant setting. 8. 11. 1 indexed citations
15.
Sun, Jingjing, et al.. (2008). Concurrent decrease in IL-10 with development of immune-related adverse events in a patient treated with anti-CTLA-4 therapy.. PubMed. 8. 9–9. 30 indexed citations
16.
Liakou, Chrysoula I., et al.. (2007). Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.. PubMed. 7. 10–10. 6 indexed citations
17.
Ghose, Romi, et al.. (2001). Antiapoptotic Function of Cdk9 (TAK/P-TEFb) in U937 Promonocytic Cells. Journal of Virology. 75(3). 1220–1228. 44 indexed citations
18.
Yang, Xinzhen, Derek Ng Tang, Dorothy E. Lewis, et al.. (1997). TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proceedings of the National Academy of Sciences. 94(23). 12331–12336. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026